More evidence is emerging that the omicron variant of the COVID-19 coronavirus affects the upper respiratory tract and causes milder symptoms than previous variants, the World Health Organization (WHO) announced.
“We are seeing more and more studies that indicate that omicron is infecting the upper body. Unlike the other (variants), which could cause severe pneumonia”, Said the head of incidents of the WHO, Abdi Mahamud, in Geneva, adding that that could be a “good news”.
However, he noted that the high transmissibility of omicron implies that within weeks it will become the dominant variant in many places, posing a threat in countries where a large part of the population remains unvaccinated.
His comments about the lower risk of a serious disease are in line with other data, including a study from South Africa, one of the first countries in which omicron was detected.
But nevertheless, Mahamud he also called for caution and called South Africa a “atypical case”, Since it has a young population, among other factors.
When asked if a specific vaccine against omicron, Mahamud He noted that it is too early to determine, but stressed that the decision requires global coordination and should not be left to the commercial sector.
.
Ricardo is a renowned author and journalist, known for his exceptional writing on top-news stories. He currently works as a writer at the 247 News Agency, where he is known for his ability to deliver breaking news and insightful analysis on the most pressing issues of the day.
